(NASDAQ: COO) Cooper Companies's forecast annual revenue growth rate of 6.1% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.68%.
Cooper Companies's revenue in 2023 is $3,593,200,000.On average, 6 Wall Street analysts forecast COO's revenue for 2024 to be $190,554,038,726, with the lowest COO revenue forecast at $189,298,208,400, and the highest COO revenue forecast at $191,606,119,162.
In 2025, COO is forecast to generate $202,751,248,047 in revenue, with the lowest revenue forecast at $200,100,815,594 and the highest revenue forecast at $206,316,821,595.